Yahoo Web Search

Search results

  1. Find the latest Avalo Therapeutics, Inc. (AVTX) stock quote, history, news and other vital information to help you with your stock trading and investing.

  2. May 22, 2024 · Avalo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the treatment of immune dysregulation by developing therapies that target the LIGHT-signaling network.

  3. Get the latest Avalo Therapeutics Inc (AVTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

  4. Avalo Therapeutics is a clinical stage biotechnology company focused on the treatment of immune dysregulation. Our Pipeline. Our pipeline emphasizes high value potential first-in-class biologics focused on dysregulated inflammation. Our Assets. Avalo’s lead asset is AVTX-009, an anti-IL-1β mAb, targeting inflammatory diseases.

  5. www.nasdaq.com › market-activity › stocksAVTX - Nasdaq

    Mar 28, 2024 · Discover real-time Avalo Therapeutics, Inc. Common Stock (AVTX) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.

    • $178.57
    • Biotechnology: Pharmaceutical Preparations
    • NASDAQ-CM
    • Health Care
  6. Sep 12, 2015 · A high-level overview of Avalo Therapeutics, Inc. (AVTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

  7. People also ask

  8. Get a real-time Avalo Therapeutics, Inc. (AVTX) stock price quote with breaking news, financials, statistics, charts and more.

  1. People also search for